Progression of herpesvirus infection remodels mitochondrial organization and metabolism

PLoS Pathog. 2024 Apr 15;20(4):e1011829. doi: 10.1371/journal.ppat.1011829. eCollection 2024 Apr.

Abstract

Viruses target mitochondria to promote their replication, and infection-induced stress during the progression of infection leads to the regulation of antiviral defenses and mitochondrial metabolism which are opposed by counteracting viral factors. The precise structural and functional changes that underlie how mitochondria react to the infection remain largely unclear. Here we show extensive transcriptional remodeling of protein-encoding host genes involved in the respiratory chain, apoptosis, and structural organization of mitochondria as herpes simplex virus type 1 lytic infection proceeds from early to late stages of infection. High-resolution microscopy and interaction analyses unveiled infection-induced emergence of rough, thin, and elongated mitochondria relocalized to the perinuclear area, a significant increase in the number and clustering of endoplasmic reticulum-mitochondria contact sites, and thickening and shortening of mitochondrial cristae. Finally, metabolic analyses demonstrated that reactivation of ATP production is accompanied by increased mitochondrial Ca2+ content and proton leakage as the infection proceeds. Overall, the significant structural and functional changes in the mitochondria triggered by the viral invasion are tightly connected to the progression of the virus infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chlorocebus aethiops
  • Disease Progression
  • Herpes Simplex* / metabolism
  • Herpes Simplex* / pathology
  • Herpes Simplex* / virology
  • Herpesviridae Infections / metabolism
  • Herpesviridae Infections / pathology
  • Herpesviridae Infections / virology
  • Herpesvirus 1, Human* / metabolism
  • Herpesvirus 1, Human* / physiology
  • Humans
  • Mitochondria* / metabolism

Grants and funding

This work was financed by the Jane and Aatos Erkko Foundation (MVR); Academy of Finland under award number 330896 (MVR) and 332615 (EM); European Union’s Horizon 2020 research and innovation program under grant agreement No 101017116, project Compact Cell-Imaging Device (CoCID; EP, TM, KF, VW, MVR); with the support of Biocentre Finland and Tampere Virus Production Facility (ED). This project benefited from access to ALBA and has been supported by iNEXT-Discovery, project number 871037, funded by the Horizon 2020 program of the European Commission (EP). This study was funded by ALBA Synchrotron standard proposals 2021095277, 2022025597, and 2022086951 (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.